Immune modulation in suckling rat pups by a growth factor extract derived from milk whey.
Oral tolerance to foreign enteral antigens is not fully developed in early neonatal life. Epidemiological evidence supports a role for maternal milk in the development of immune responses, including oral tolerance. Formula fed infants have an increased susceptibility to food allergy and the later development of autoimmune disease. This may relate to the lack in infant formula of growth factors found in maternal milk. Bovine milk contains proteins, growth factors and cytokines. Various studies have outlined the immune modulating potential of bovine milk-derived products. Fractionated whey extracts have therapeutic potential in disease states where there is an excessive inflammatory reaction, and disease preventive potential for infants who are not breast-fed. We have shown that daily oral administration of a growth factor-enriched fraction from milk whey to naturally suckling rat pups between days 4-9 postnatal can down-regulate immune activation to a specific orally administered food antigen, ovalbumin, assessed by lymphocyte proliferation. In addition, non-specific down-regulation in the intestine was observed as assessed by the expression of MHC I. Treatment of rat pups with whey extract at the time of oral sensitisation to ovalbumin also resulted in an increased secretion of TGF-beta into the culture supernatant of spleen cells incubated with specific antigen. TGF-beta is an immuno-down-regulatory cytokine involved in tolerance induction. Immune modulation by extracts derived from milk whey could be of potential benefit for formula-fed and pre-term infants in reducing susceptibility to inappropriate activation to food antigens.
Penttila
I A
IA
CRC for Tissue Growth and Repair, Child Health Research Institute, North Adelaide, South Australia. irmeli.penttila@adelaide.edu.au
Zhang
M F
MF
Bates
E
E
Regester
G
G
Read
L C
LC
Zola
H
H
D000818:Animals; D000833:Animals, Suckling / Q000276:immunology*; D004847:Epithelial Cells / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006133:Growth Substances / Q000008:administration & dosage*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D007108:Immune Tolerance; D007109:Immunity / Q000187:drug effects*; D007371:Interferon-gamma / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D008233:Lymphotoxin-alpha / Q000378:metabolism; D008892:Milk / Q000737:chemistry*; D008894:Milk Proteins / Q000737:chemistry*; D010047:Ovalbumin / Q000276:immunology; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000276:immunology; D014020:Tissue Extracts / Q000008:administration & dosage; D000067816:Whey Proteins
D006133:Growth Substances; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D008233:Lymphotoxin-alpha; D008894:Milk Proteins; D014020:Tissue Extracts; D000067816:Whey Proteins; D007371:Interferon-gamma; D010047:Ovalbumin